Ethylene oxide-protein adduct formation in humans: influence of glutathione- S -transferase polymorphisms

1998 ◽  
Vol 71 (7) ◽  
pp. 499-502 ◽  
Author(s):  
M. Müller ◽  
A. Krämer ◽  
J. Angerer ◽  
E. Hallier
Author(s):  
Matthew P. Sullivan ◽  
Monika Cziferszky ◽  
Iogann Tolbatov ◽  
Dianna Truong ◽  
Davide Mercadante ◽  
...  

2021 ◽  
Author(s):  
Matthew P. Sullivan ◽  
Monika Cziferszky ◽  
Iogann Tolbatov ◽  
Dianna Truong ◽  
Davide Mercadante ◽  
...  

2016 ◽  
Vol 27 (2) ◽  
pp. 128-135 ◽  
Author(s):  
S. Mathan Kumar ◽  
Madhumitha Haridoss ◽  
Kavitha Swaminathan ◽  
Ramesh Kumar Gopal ◽  
Dahn Clemens ◽  
...  

Antioxidants ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 446
Author(s):  
Seung-Cheol Jee ◽  
Min Kim ◽  
Kyeong Seok Kim ◽  
Hyung-Sik Kim ◽  
Jung-Suk Sung

Benzo[a]pyrene (B[a]P), a group 1 carcinogen, induces mutagenic DNA adducts. Myricetin is present in many natural foods with diverse biological activities, such as anti-oxidative and anti-cancer activities. The aim of this study was to investigate the protective effects of myricetin against B[a]P-induced toxicity. Treatment of B[a]P induced cytotoxicity on HepG2 cells, whereas co-treatment of myricetin with B[a]P reduced the formation of the B[a]P-7,8-dihydrodiol-9,10-epoxide (BPDE)-DNA adduct, which recovered cell viability. Furthermore, we found a protective effect of myricetin against B[a]P-induced genotoxicity in rats, via myricetin-induced inhibition of 8-hydroxy-2′-deoxyguanosine (8-OHdG) and BPDE-DNA adduct formation in the liver, kidney, colon, and stomach tissue. This inhibition was more prominent in the liver than in other tissues. Correspondingly, myricetin regulated the phase I and II enzymes that inhibit B[a]P metabolism and B[a]P metabolites conjugated with DNA by reducing and inducing CYP1A1 and glutathione S-transferase (GST) expression, respectively. Taken together, this showed that myricetin attenuated B[a]P-induced genotoxicity via regulation of phase I and II enzymes. Our results suggest that myricetin is anti-genotoxic, and prevents oxidative DNA damage and BPDE-DNA adduct formation via regulation of phase I and II enzymes.


Hepatology ◽  
2015 ◽  
Vol 62 (3) ◽  
pp. 876-886 ◽  
Author(s):  
Nurdan Guldiken ◽  
Qin Zhou ◽  
Ozlem Kucukoglu ◽  
Melanie Rehm ◽  
Kateryna Levada ◽  
...  

2015 ◽  
Vol 62 ◽  
pp. S767-S768
Author(s):  
N. Guldiken ◽  
Q. Zhou ◽  
O. Kucukoglu ◽  
M. Rehm ◽  
K. Levada ◽  
...  

2004 ◽  
Vol 50 (1) ◽  
pp. 82-85
Author(s):  
Yoshiro Saito ◽  
Mayumi Saeki ◽  
Keiko Maekawa ◽  
Akiko Hachisuka ◽  
Reiko Teshima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document